Science & Enterprise subscription

Please share Science & Enterprise

RSS
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

A.I. Drug Discovery Company Gains $32M in Early Funds

Brain hemispheres graphic

A company using genomic databases and artificial intelligence to discover new therapies for neurodegenerative diseases is raising $32 million in its first venture funding round. . . . → Read More: A.I. Drug Discovery Company Gains $32M in Early Funds

New $315 Million Life Sciences Venture Fund Unveiled

Investment graphic

A life science and health care investment company in the U.K. today revealed its 12th venture capital fund for start-up and current enterprises in the U.S. and Europe. . . . → Read More: New $315 Million Life Sciences Venture Fund Unveiled

Bacterial Genome Recoded to Produce Stable Protein Drugs

E. coli bacteria

A biotechnology lab devised techniques for genetically engineered bacteria to produce synthetic proteins that can last longer and are more stable than current protein production methods. . . . → Read More: Bacterial Genome Recoded to Produce Stable Protein Drugs

Infographic – Graphene Investment in Decline

Investments in graphene start-ups

In a report this week, our friends at CB Insights note that the investment community is waiting for graphene to reach a critical commercial mass, but their patience may be running out. . . . → Read More: Infographic – Graphene Investment in Decline

Genetic Repair Company Starts-Up, Gains $87 Million

David Liu

A company is getting underway to develop therapies that extend genome editing to repair genetic disruptions, not just remove them from DNA. . . . → Read More: Genetic Repair Company Starts-Up, Gains $87 Million

Genentech Gains Microbe Drug Discovery Tech in $1B Deal

Collecting soil samples

Biotechnology company Genentech is licensing a process from a start-up enterprise that discovers small molecule drugs from naturally occurring microbes found in soil. . . . → Read More: Genentech Gains Microbe Drug Discovery Tech in $1B Deal

Infographic – Google Health Care Investments Take Off

Google health investments

One indicator of Google’s expanding involvement in health care is its venture investments in digital health and health technology start-ups, which is this weekend’s infographic. . . . → Read More: Infographic – Google Health Care Investments Take Off

New Cell Therapy Company Raises $58.5M in Early Funds

Investment graphic

A start-up enterprise is discovering therapies to address a variety of disorders that result from faulty cell degradation processes known as autophagy, which when functioning normally contribute to cell health. . . . → Read More: New Cell Therapy Company Raises $58.5M in Early Funds

New Company Acquires Off-the-Shelf T-Cell Cancer Therapies

A new enterprise is formed to develop treatments for cancer using donated T-cells from the immune system, rather than the patient’s own T-cells, engineered to attack cancer cells. . . . → Read More: New Company Acquires Off-the-Shelf T-Cell Cancer Therapies

Nerve Stimulation Device Being Tested for Arthritis

A device sending electrical pulses through a main nerve pathway is starting a clinical trial to test the device in people with rheumatoid arthritis, an autoimmune disease affecting joints and surrounding tissue. . . . → Read More: Nerve Stimulation Device Being Tested for Arthritis